A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial. Anstey, K. J., Bahar-Fuchs, A., Herath, P., Rebok, G. W., & Cherbuin, N. Trials, 14:60, 2013. MultiPaper doi abstract bibtex Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is also well known that AD-related pathological processes begin more than a decade before the development of clinical signs. These observations suggest that lifestyle interventions might be most effective when targeting non-symptomatic adults at risk of AD. To date, however, the few dementia risk-reduction programs available have targeted individual risk factors and/or were restricted to clinical settings. The current study describes the development of an evidence-based, theoretically-driven multidomain intervention to reduce AD risk in adults at risk.
@article{anstey_12-week_2013,
title = {A 12-week multidomain intervention versus active control to reduce risk of {Alzheimer}’s disease: study protocol for a randomized controlled trial},
volume = {14},
issn = {1745-6215},
shorttitle = {A 12-week multidomain intervention versus active control to reduce risk of {Alzheimer}’s disease},
url = {http://dx.doi.org/10.1186/1745-6215-14-60},
doi = {10.1186/1745-6215-14-60},
abstract = {Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is also well known that AD-related pathological processes begin more than a decade before the development of clinical signs. These observations suggest that lifestyle interventions might be most effective when targeting non-symptomatic adults at risk of AD. To date, however, the few dementia risk-reduction programs available have targeted individual risk factors and/or were restricted to clinical settings. The current study describes the development of an evidence-based, theoretically-driven multidomain intervention to reduce AD risk in adults at risk.},
urldate = {2017-02-08},
journal = {Trials},
author = {Anstey, Kaarin J. and Bahar-Fuchs, Alex and Herath, Pushpani and Rebok, George W. and Cherbuin, Nicolas},
year = {2013},
note = {Multi},
keywords = {Alzheimer’s Disease, Behavior change, Cardiovascular risk factors, Diet, Internet, RCT, physical activity},
pages = {60}
}
Downloads: 0
{"_id":"zwoZpKL5GrnG4AkuB","bibbaseid":"anstey-baharfuchs-herath-rebok-cherbuin-a12weekmultidomaininterventionversusactivecontroltoreduceriskofalzheimersdiseasestudyprotocolforarandomizedcontrolledtrial-2013","authorIDs":[],"author_short":["Anstey, K. J.","Bahar-Fuchs, A.","Herath, P.","Rebok, G. W.","Cherbuin, N."],"bibdata":{"bibtype":"article","type":"article","title":"A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial","volume":"14","issn":"1745-6215","shorttitle":"A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease","url":"http://dx.doi.org/10.1186/1745-6215-14-60","doi":"10.1186/1745-6215-14-60","abstract":"Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is also well known that AD-related pathological processes begin more than a decade before the development of clinical signs. These observations suggest that lifestyle interventions might be most effective when targeting non-symptomatic adults at risk of AD. To date, however, the few dementia risk-reduction programs available have targeted individual risk factors and/or were restricted to clinical settings. The current study describes the development of an evidence-based, theoretically-driven multidomain intervention to reduce AD risk in adults at risk.","urldate":"2017-02-08","journal":"Trials","author":[{"propositions":[],"lastnames":["Anstey"],"firstnames":["Kaarin","J."],"suffixes":[]},{"propositions":[],"lastnames":["Bahar-Fuchs"],"firstnames":["Alex"],"suffixes":[]},{"propositions":[],"lastnames":["Herath"],"firstnames":["Pushpani"],"suffixes":[]},{"propositions":[],"lastnames":["Rebok"],"firstnames":["George","W."],"suffixes":[]},{"propositions":[],"lastnames":["Cherbuin"],"firstnames":["Nicolas"],"suffixes":[]}],"year":"2013","note":"Multi","keywords":"Alzheimer’s Disease, Behavior change, Cardiovascular risk factors, Diet, Internet, RCT, physical activity","pages":"60","bibtex":"@article{anstey_12-week_2013,\n\ttitle = {A 12-week multidomain intervention versus active control to reduce risk of {Alzheimer}’s disease: study protocol for a randomized controlled trial},\n\tvolume = {14},\n\tissn = {1745-6215},\n\tshorttitle = {A 12-week multidomain intervention versus active control to reduce risk of {Alzheimer}’s disease},\n\turl = {http://dx.doi.org/10.1186/1745-6215-14-60},\n\tdoi = {10.1186/1745-6215-14-60},\n\tabstract = {Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is also well known that AD-related pathological processes begin more than a decade before the development of clinical signs. These observations suggest that lifestyle interventions might be most effective when targeting non-symptomatic adults at risk of AD. To date, however, the few dementia risk-reduction programs available have targeted individual risk factors and/or were restricted to clinical settings. The current study describes the development of an evidence-based, theoretically-driven multidomain intervention to reduce AD risk in adults at risk.},\n\turldate = {2017-02-08},\n\tjournal = {Trials},\n\tauthor = {Anstey, Kaarin J. and Bahar-Fuchs, Alex and Herath, Pushpani and Rebok, George W. and Cherbuin, Nicolas},\n\tyear = {2013},\n\tnote = {Multi},\n\tkeywords = {Alzheimer’s Disease, Behavior change, Cardiovascular risk factors, Diet, Internet, RCT, physical activity},\n\tpages = {60}\n}","author_short":["Anstey, K. J.","Bahar-Fuchs, A.","Herath, P.","Rebok, G. W.","Cherbuin, N."],"key":"anstey_12-week_2013","id":"anstey_12-week_2013","bibbaseid":"anstey-baharfuchs-herath-rebok-cherbuin-a12weekmultidomaininterventionversusactivecontroltoreduceriskofalzheimersdiseasestudyprotocolforarandomizedcontrolledtrial-2013","role":"author","urls":{"Paper":"http://dx.doi.org/10.1186/1745-6215-14-60"},"keyword":["Alzheimer’s Disease","Behavior change","Cardiovascular risk factors","Diet","Internet","RCT","physical activity"],"downloads":0},"bibtype":"article","biburl":"https://api.zotero.org/groups/703923/items?key=qE2oEfCFnGTtfnkWGD2qWwCc&format=bibtex&limit=100","creationDate":"2019-05-23T20:58:54.085Z","downloads":0,"keywords":["alzheimer’s disease","behavior change","cardiovascular risk factors","diet","internet","rct","physical activity"],"search_terms":["week","multidomain","intervention","versus","active","control","reduce","risk","alzheimer","disease","study","protocol","randomized","controlled","trial","anstey","bahar-fuchs","herath","rebok","cherbuin"],"title":"A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial","year":2013,"dataSources":["XZ7zCjyxvK2aqm9z2"]}